第一项始终是图钉的来源。总体可信度是各份资料对上方所用开始和结束时间支持程度的加权平均;资料每比最新的一份旧 180 天,权重减半。
Confirmed by J&J's release dated "New Brunswick, N.J. (July 15, 2026)", which says it "will conduct a conference call with investors to discuss this earnings release today at 8:30 a.m., Eastern Time" (12:30 UTC; the edited transcript is stamped "JULY 15, 2026 / 12:30PM GMT").
MarketBeat: "Johnson & Johnson issued Q2 2026 earnings on July 15, 2026, reporting an EPS of $2.90, which beat analysts' consensus estimates of $2.84"; revenue $25.31 billion against $25.06 billion. An aggregator, so kept low.
J&J's investor note says that on 29 July it published an 8-K updating FY 2026 guidance for the Firefly Bio and Sail Biomedicines deals, the follow-up to the guidance raised on 15 July.[1]
J&J's own posted transcript of the 15 July call ("JULY 15, 2026 / 12:30PM GMT"): the CFO says results "enabled us to confidently raise our" outlook and points to the enterprise business review on 8 December.[1]
CNBC reports on 15 July that J&J beat estimates with $25.31 billion in sales against about $25.05 billion expected and $2.90 adjusted EPS against $2.85, and raised its full-year forecast.
有遗漏或错误吗?用你自己的话说明:能佐证此图钉的链接、不同的开始或结束日期及理由,或缺失、有误的信息。AI 会对照此图钉的来源进行核实,搜索更好的来源,并添加任何支持你说法的页面。图钉自身的来源仍然最重要。